1. Signaling Pathways
  2. GPCR/G Protein
  3. Arf Family GTPase

Arf Family GTPase (ADP核糖基化因子 GTP 酶)

ADP-ribosylation Factor (ARF) Family GTPase

ADP 核糖化因子 (Arf) GTP 酶 (ARF GTPases) 是 Ras 超家族下小 GTP 酶的一个亚家族。哺乳动物中约包含 30 种 ARF GTPases 家族成员,分为”真正的ARFs” (6种) 和 “ARF样” (ARL) 蛋白 (21种),以及 SARs 等其他相关蛋白。ARF GTPases 在调节膜交通和细胞器结构中起关键作用。在鸟苷核苷酸交换因子 (GEFs) 和 GTPase 激活蛋白 (GAPs) 介导下通过 GTP 结合和水解的方式进行激活和被激活。ARF GTPases 调控多种关键细胞过程,如囊泡形成、蛋白质排序、脂质改造和细胞骨架动态,从而影响分泌、内吞作用和细胞粘附等细胞功能。其活性涉及与多种效应器的相互作用,包括涂层蛋白、脂质修饰酶和脚手架蛋白。 ARF GTPases 的异常表达或功能失调与多种疾病状态有关,包括神经退行性疾病、肿瘤和免疫系统疾病。特别地,ARF GTPases 在膜组织重塑和细胞信号传导中的作用使得它们成为研究这些疾病的潜在靶点[1]

ADP-ribosylation factor (Arf) GTPases are a subfamily of the Ras superfamily of small GTPases. In mammals, there are approximately 30 members of the ARF GTPases family, divided into "true ARFs" (6 types) and "ARF-like" (ARL) proteins (21 types), as well as other related proteins such as SARs. ARF GTPases play a crucial role in regulating membrane trafficking and organelle structure. They are activated and deactivated through GTP binding and hydrolysis, mediated by guanine nucleotide exchange factors (GEFs) and GTPase-activating proteins (GAPs). ARF GTPases regulate a variety of key cellular processes such as vesicle formation, protein sorting, lipid remodeling, and the dynamics of the cytoskeleton, thereby affecting secretion, endocytosis, and cell adhesion. Their activity involves interactions with a variety of effectors, including coat proteins, lipid-modifying enzymes, and scaffold proteins.
The aberrant expression or dysfunction of ARF GTPases is associated with various disease states, including neurodegenerative diseases, tumors, and immune system disorders. Specifically, the role of ARF GTPases in membrane remodeling and cell signaling makes them potential targets for research into these diseases[1].

Arf Family GTPase 相关产品 (2):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-111549
    Bragsin1 Inhibitor 99.40%
    Bragsin1 是一种有效、选择性、非竞争性的核苷酸交换因子 ArfGEF BRAG2 抑制剂,抑制 Arf GTPase 活化,IC50 值为 3 μM。Bragsin1 与 BRAG2 的 PH 结构域结合,为非竞争性界面抑制剂,对人 ArfGEFs 的 Sec7 结构域无作用。具有抗肿瘤活性。
    Bragsin1
  • HY-P10179
    ARF6 (2-13)
    ARF6 (2-13) 是一种序列为 GKVLSKIFGNKE 的肽。 ARF6 (2-13) 是 ARF6 的抑制剂。 ARF6 (2-13) 可用于内毒素血症的研究。
    ARF6 (2-13)